Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 1 pseudogene 18 (HMGB1P18) is a non-functional DNA sequence in the human genome that is designated as a pseudogene related to the HMGB1 family. While typical pseudogenes do not encode functional proteins, they may, in some cases, regulate gene expression by RNA-based mechanisms, such as serving as competing endogenous RNAs or producing small interfering RNAs. There is no direct evidence that HMGB1P18 itself has a biological function or disease role, and it is not considered a therapeutic target. It is classified simply as a pseudogene and follows typical nomenclature for human pseudogenes derived from parent genes.
None; not druggable or therapeutically targeted
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 1 pseudogene 18 (HMGB1P18).